findmyKOL

Sarah Kaplan, MD

Basic profile

Columbia University

ORCIDNone on fileNPI
RegionNew York, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Sarah Kaplan is a Cardiology physician affiliated with Columbia University. OpenAlex indexes 5 publications with 599 citations (h-index 5).

Overview

Scholarship

indexed output and impact (OpenAlex)
5publications

Distinct works indexed by OpenAlex.

599citations

Total citations across indexed works.

5h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.9%
    Statin28.7%
    Rosuvastatin Calcium52%Atorvastatin Calcium38%Simvastatin4%Pravastatin Sodium3%Livalo2%
    Part D<11 patients
    Beta blocker18.7%
    Metoprolol Succinate53%Carvedilol16%Metoprolol Tartrate11%Bisoprolol Fumarate11%Nebivolol Hcl6%Atenolol3%
    Part D<11 patients

    + 10 more classes in this area

  • Blood & clotting

    11.4%
    Factor Xa inhibitor7%
    Eliquis61%Xarelto39%
    Part D29 patients
    P2Y12 inhibitor3.8%
    Clopidogrel100%
    Part D27 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    0.7%
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)14.4% facility · 85.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”